Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

NCT06899061 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignancies

Interventions

DRUG: Saruparib
DRUG: Digoxin
DRUG: Furosemide
DRUG: Metformin Hydrochloride
DRUG: Rosuvastatin
DRUG: Rabeprazole

Sponsor

AstraZeneca

Collaborators

[object Object]